Pharmaceutical composition comprising ruxolitinib
Provided is a solid oral pharmaceutical composition comprising as an active pharmaceutical ingredient ruxolitinib or a pharmaceutically acceptable salt thereof wherein the composition contains less than 2.0% by weight of povidone. Moreover, Provided is the process for the preparation of the pharmace...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Provided is a solid oral pharmaceutical composition comprising as an active pharmaceutical ingredient ruxolitinib or a pharmaceutically acceptable salt thereof wherein the composition contains less than 2.0% by weight of povidone. Moreover, Provided is the process for the preparation of the pharmaceutical composition.
L'invention concerne une composition pharmaceutique orale solide comprenant en tant qu'ingrédient pharmaceutique actif du ruxolitinib ou un sel pharmaceutiquement acceptable de celui-ci, la composition contenant moins de 2,0 % en poids de povidone. De plus, l'invention concerne le procédé de préparation de la composition pharmaceutique. |
|---|